Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer

NCT04383743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Stage II Bladder Cancer AJCC v8
Stage IIIA Bladder Cancer AJCC v8
Muscle Invasive Bladder Carcinoma

Interventions

DRUG: Cisplatin
DRUG: Doxorubicin
DRUG: Methotrexate
BIOLOGICAL: Pegfilgrastim
BIOLOGICAL: Pembrolizumab
PROCEDURE: Radical Cystectomy
DRUG: Vinblastine Sulfate

Sponsor

University of Washington

Collaborators

[object Object]